Skip to main content

For Patients

Patient FAQ

Answers to the most common questions about OBRI and what it means to participate.

General Questions

The Ontario Best Practices Research Initiative (OBRI) is an academic research initiative based at the University Health Network in Toronto. Founded in 2005, OBRI collects long-term, real-world data from patients living with rheumatoid arthritis (RA) in Ontario. Our goal is to improve the quality of care and clinical outcomes for arthritis patients by generating evidence that reflects everyday clinical practice.

The best way to join is to speak with your rheumatologist at your next appointment. If your clinic participates in OBRI, your care team can tell you more about the study and help you get started. You can also contact OBRI directly at Angela.Cesta@uhn.ca to find out whether a clinic near you is part of the network.

About Participation

Adults who have been diagnosed with psoriatic arthritis and are receiving care from a rheumatologist at a participating OBRI clinic may be eligible to join. Your rheumatologist can tell you whether their clinic is part of the OBRI network and whether you may be eligible to participate.

Participation in OBRI involves providing consent to join the study and completing telephone or online interviews at regular intervals — typically when you join, then at 3 months, 6 months, and every 6 months after that. These interviews collect information about your medical history, current medications, disease symptoms, and quality of life. Your rheumatologist will also provide information from your clinic visits, such as laboratory results and disease activity assessments.

No. Participating in OBRI does not change your usual medical care in any way. You will continue to see your rheumatologist and receive treatment as you normally would. OBRI simply collects information about your care and experiences — it does not direct or influence treatment decisions.

We hope participants will be able to stay involved for at least two years, as long-term follow-up is essential to understanding how treatments work over time. However, participation is entirely voluntary. You may withdraw from OBRI at any time and for any reason, without any effect on your medical care.

Privacy & Data

OBRI takes participant privacy very seriously. All personal information is stored securely and is accessible only to authorized research staff. Data used in publications and reports is de-identified, meaning your name and other identifying details are never shared. OBRI operates in accordance with the Personal Health Information Protection Act (PHIPA) and University Health Network research ethics requirements.

Only authorized OBRI research staff have access to information that could identify you. Researchers and collaborators working with OBRI data receive de-identified datasets only. Your information will never be shared with your employer, insurance company, or anyone outside the research team without your explicit consent.

Research & Impact

Your participation contributes to a growing body of real-world evidence that helps improve treatment for everyone living with RA. OBRI findings have informed drug policy decisions, clinical guidelines, and research priorities at the provincial and national level. Without patient participants, this kind of long-term, real-world research would not be possible.

OBRI publishes research findings in peer-reviewed academic journals and presents at national and international conferences. Plain-language summaries of key findings are available in our Patient Resources section, written specifically for participants and the public. We also share updates through our News section.

Still have questions?

The OBRI study team is happy to answer any additional questions.

Contact Us